Results 101 to 110 of about 19,009 (196)

Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development

open access: yes
Clinical and Translational Science, Volume 19, Issue 11, November 2026.
Paridhi Gupta   +3 more
wiley   +1 more source

Comparison of P15ink4b methylation before and after decitabine regimens.

open access: yes, 2014
p15 methylation level decreased after decitabine treatment in responders (n = 41) (A); p15 methylation level elevated slightly after decitabine treatment in nonresponders (n = 18) (B).
Xi Zhang (83736)   +12 more
core   +1 more source

Decitabine reduced GFP-positive rates (%GFP) in transduced human CD34+ cells.

open access: yes, 2014
(a). Human CD34+ cells were cultured in serum-free media containing cytokines (SCF, FLT3L, and TPO). After 24 hours of prestimulation, the cells were transduced with GFP-expressing HIV-1 based lentiviral vectors for 24 hours.
Yogen Saunthararajah (320626)   +4 more
core   +1 more source

DISRUPTION OF THE RNF4/STUbL PATHWAY SENSITIZES TO DECITABINE THROUGH IMPAIRED CLEARANCE OF DNMT1-DNA COVALENT COMPLEXES

open access: yes, 2021
The epigenetic drug Decitabine is a cytidine nucleoside analog DNA methyltransferase inhibitor that is used in the treatment of myelodysplastic syndrome (MDS) and leukemia and is being investigated in the treatment of numerous other cancers and diseases.
Tselenchuk, Dimitri
core  

Study Design: Platinum resistant ovarian cancer subjects treated with decitabine and carboplatin.

open access: yes, 2015
Fourteen platinum resistant ovarian cancer patients were treated with decitabine/carboplatin in a phase II clinical trial. For the first chemotherapy cycle, decitabine was given daily for 5 days; followed by carboplatin given on day 8.
Kenneth P. Nephew (212536)   +4 more
core   +1 more source

Decitabine and Cedazuridine

open access: yesAmerican Journal of Health-System Pharmacy, 2020
openaire   +2 more sources

The Mouse Mammary Tumor Virus Mediates the Antineoplastic Action of Decitabine [PDF]

open access: yes
The purpose of this study is to clarify the role of the mouse mammary tumor virus (MMTV) in the antineoplastic effect of decitabine, a DNA demethylating agent.
Brola, Andrew
core   +2 more sources

Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for Induction Chemotherapy and Impact of Oral Formulation Introduction: A Micro-Costing Study in Italy

open access: yesClinicoEconomics and Outcomes Research
Alessandra Di Costanzo, Luca Loreto, Chiara Vassallo, Francesca Fiorentino Real World Solutions, IQVIA Solutions Italy S.r.l., Milan, ItalyCorrespondence: Chiara Vassallo, Real World Solutions, IQVIA Solutions Italy s.r.l., Via Fabio Filzi 29, Milan ...
Di Costanzo A   +3 more
doaj  

Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy

open access: yes
Background/Objectives: Triple-negative breast cancer (TNBC) is an aggressive subtype lacking ER, PR, and HER2 expression, with limited targeted therapies and poor outcomes. Epigenetic dysregulation, particularly aberrant DNA methylation, is a key driver.
Fathima Raahima Riyas Mohamed   +9 more
core   +1 more source

New decitabine nanoparticle formulations to acute myeloid leukemia treatments

open access: yes, 2018
Ces travaux de thèse ont porté sur le développement de formulations innovantes et nanoparticulaire, destinées à améliorer la prise en charge des patients atteints de leucémie aigüe myéloïdes (LAM).
Briot, Thomas
core  

Home - About - Disclaimer - Privacy